<DOC>
	<DOCNO>NCT01593579</DOCNO>
	<brief_summary>Some Akt inhibitor produce functional cardiovascular effect mark hypotension may limit clinical benefit . There current data whether autonomic failure present human clinically use dos . We test hypothesis Akt inhibition cause acute decrease sympathetic tone lower blood pressure .</brief_summary>
	<brief_title>Autonomic Phenotype Before After Akt Inhibition</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>Diagnosed melanoma BRAF mutation relapse follow therapy BRAF inhibitor Enrolled clinical trial Vanderbilt Ingram Cancer Center ( VICC ) include arm oral Akt inhibitor Able willing provide inform consent Factors investigator 's opinion would prevent participant complete protocol , include poor compliance previous study unpredictable schedule Unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>melanoma</keyword>
	<keyword>autonomic failure</keyword>
	<keyword>hypotension</keyword>
	<keyword>akt therapy</keyword>
</DOC>